Nanosonics Limited (NAN.AX)
AUD 2.96
(-1.0%)
AUD 2.96
(-1.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | 21.72 Million AUD | -26.37% |
| 2023 | 29.5 Million AUD | 285.57% |
| 2022 | 7.86 Million AUD | -49.09% |
| 2021 | 15.74 Million AUD | -17.66% |
| 2020 | 16.69 Million AUD | 0.44% |
| 2019 | 19.21 Million AUD | 278.84% |
| 2018 | 7.14 Million AUD | -71.2% |
| 2017 | 15.16 Million AUD | 1689.28% |
| 2016 | 2.06 Million AUD | 113.4% |
| 2015 | -3.89 Million AUD | -189.67% |
| 2014 | -1.1 Million AUD | 51.05% |
| 2013 | -4.17 Million AUD | 30.96% |
| 2012 | -6.04 Million AUD | 53.4% |
| 2011 | -12.97 Million AUD | -42.28% |
| 2010 | -9.11 Million AUD | 9.7% |
| 2009 | -10.09 Million AUD | 1.02% |
| 2008 | -6.9 Million AUD | -19.18% |
| 2007 | -5.54 Million AUD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 7.4 Million AUD | 0.0% |
| 2024 FY | - AUD | -36.27% |
| 2024 Q4 | 7.32 Million AUD | 0.0% |
| 2023 Q4 | 11.44 Million AUD | 0.0% |
| 2023 FY | - AUD | 285.57% |
| 2023 Q2 | 13.68 Million AUD | 0.0% |
| 2022 Q4 | 1.68 Million AUD | 0.0% |
| 2022 FY | - AUD | -49.09% |
| 2022 Q2 | 4.83 Million AUD | 0.0% |
| 2021 FY | - AUD | -17.66% |
| 2021 Q2 | 3.23 Million AUD | 0.0% |
| 2021 Q4 | 9.57 Million AUD | 0.0% |
| 2020 Q2 | 7.6 Million AUD | 0.0% |
| 2020 Q4 | 8.62 Million AUD | 0.0% |
| 2020 FY | - AUD | 0.44% |
| 2019 Q4 | 5.42 Million AUD | 0.0% |
| 2019 Q2 | 10.06 Million AUD | 0.0% |
| 2019 FY | - AUD | 278.84% |
| 2018 FY | - AUD | -71.2% |
| 2018 Q4 | 304 Thousand AUD | 0.0% |
| 2018 Q2 | 3.78 Million AUD | 0.0% |
| 2017 Q2 | 9.79 Million AUD | 0.0% |
| 2017 FY | - AUD | 1689.28% |
| 2017 Q4 | 4.39 Million AUD | 0.0% |
| 2016 Q2 | -3.04 Million AUD | 0.0% |
| 2016 FY | - AUD | 113.4% |
| 2016 Q4 | 3.83 Million AUD | 0.0% |
| 2015 Q4 | -6.97 Million AUD | 0.0% |
| 2015 FY | - AUD | -189.67% |
| 2015 Q2 | 1.05 Million AUD | 0.0% |
| 2014 FY | - AUD | 51.05% |
| 2014 Q4 | 1.06 Million AUD | 0.0% |
| 2014 Q2 | -3.11 Million AUD | 0.0% |
| 2013 Q1 | -1.09 Million AUD | 0.0% |
| 2013 FY | - AUD | 30.96% |
| 2013 Q4 | 601 Thousand AUD | 157.59% |
| 2013 Q3 | -1.04 Million AUD | 82.63% |
| 2013 Q2 | -6 Million AUD | -446.59% |
| 2012 Q3 | -1.09 Million AUD | 0.0% |
| 2012 FY | - AUD | 53.4% |
| 2012 Q1 | -2.72 Million AUD | 0.0% |
| 2012 Q2 | -1.09 Million AUD | 59.71% |
| 2012 Q4 | -1.09 Million AUD | 0.0% |
| 2011 Q4 | -2.72 Million AUD | 0.0% |
| 2011 Q1 | -1.85 Million AUD | 0.0% |
| 2011 FY | - AUD | -42.28% |
| 2011 Q3 | -2.72 Million AUD | 0.0% |
| 2011 Q2 | -2.72 Million AUD | -47.39% |
| 2010 Q1 | -2.08 Million AUD | 0.0% |
| 2010 Q3 | -1.85 Million AUD | 0.0% |
| 2010 Q4 | -1.85 Million AUD | 0.0% |
| 2010 Q2 | -1.85 Million AUD | 11.18% |
| 2010 FY | - AUD | 9.7% |
| 2009 Q3 | -2.08 Million AUD | 0.0% |
| 2009 Q4 | -2.08 Million AUD | 0.0% |
| 2009 Q1 | -1.72 Million AUD | 0.0% |
| 2009 Q2 | -2.08 Million AUD | -20.69% |
| 2009 FY | - AUD | 1.02% |
| 2008 Q1 | -1.38 Million AUD | 0.0% |
| 2008 FY | - AUD | -19.18% |
| 2008 Q3 | -1.72 Million AUD | 0.0% |
| 2008 Q2 | -1.72 Million AUD | -24.58% |
| 2008 Q4 | -1.72 Million AUD | 0.0% |
| 2007 FY | - AUD | 0.0% |
| 2007 Q4 | -1.38 Million AUD | 0.0% |
| 2007 Q3 | -1.38 Million AUD | 0.0% |
| 2007 Q2 | -1.38 Million AUD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Austco Healthcare Limited | 8.11 Million AUD | -167.722% |
| Osteopore Limited | -4.34 Million AUD | 599.492% |
| SDI Limited | 20.96 Million AUD | -3.64% |
| Trajan Group Holdings Limited | -20.35 Million AUD | 206.71% |